BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND LRP1B, ENSG00000168702, 53353, Q9NZR2, LRPDIT, LRP-DIT
9 results:

  • 1. Whole-exome sequencing of Nigerian benign prostatic hyperplasia reveals increased alterations in apoptotic pathways.
    White JA; Kaninjing ET; Adeniji KA; Jibrin P; Obafunwa JO; Ogo CN; Mohammed F; Popoola A; Fatiregun OA; Oluwole OP; Thorpe RJ; Karanam B; Elhussin I; Ambs S; Tang W; Davis M; Polak P; Campbell MJ; Brignole KR; Rotimi SO; Dean-Colomb W; Odedina FT; Yates C
    Prostate; 2024 Apr; 84(5):460-472. PubMed ID: 38192023
    [TBL] [Abstract] [Full Text] [Related]  

  • 2.
    Brown LC; Tucker MD; Sedhom R; Schwartz EB; Zhu J; Kao C; Labriola MK; Gupta RT; Marin D; Wu Y; Gupta S; Zhang T; Harrison MR; George DJ; Alva A; Antonarakis ES; Armstrong AJ
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33653800
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. TP53 alterations of hormone-naïve prostate cancer in the Chinese population.
    Liu Z; Guo H; Zhu Y; Xia Y; Cui J; Shi K; Fan Y; Shi B; Chen S
    Prostate Cancer Prostatic Dis; 2021 Jun; 24(2):482-491. PubMed ID: 33214693
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Distinct Genomic Alterations in prostate Tumors Derived from African American Men.
    Liu W; Zheng SL; Na R; Wei L; Sun J; Gallagher J; Wei J; Resurreccion WK; Ernst S; Sfanos KS; Isaacs WB; Xu J
    Mol Cancer Res; 2020 Dec; 18(12):1815-1824. PubMed ID: 33115829
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Hypoxia induced microRNA-301b-3p overexpression promotes proliferation, migration and invasion of prostate cancer cells by targeting lrp1b.
    Zheng H; Bai L
    Exp Mol Pathol; 2019 Dec; 111():104301. PubMed ID: 31442444
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Neoantigens Derived from Recurrently Mutated Genes as Potential Immunotherapy Targets for Gastric cancer.
    Zhou J; Zhao W; Wu J; Lu J; Ding Y; Wu S; Wang H; Ding D; Mo F; Zhou Z; Teng L; Chen S
    Biomed Res Int; 2019; 2019():8103142. PubMed ID: 31312661
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Pembrolizumab in men with heavily treated metastatic castrate-resistant prostate cancer.
    Tucker MD; Zhu J; Marin D; Gupta RT; Gupta S; Berry WR; Ramalingam S; Zhang T; Harrison M; Wu Y; Healy P; Lisi S; George DJ; Armstrong AJ
    Cancer Med; 2019 Aug; 8(10):4644-4655. PubMed ID: 31270961
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. miR-500 promotes cell proliferation by directly targetting lrp1b in prostate cancer.
    Zhang Z; Cui R; Li H; Li J
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30877185
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Integrative analysis of cancer driver genes in prostate adenocarcinoma.
    Zhao X; Lei Y; Li G; Cheng Y; Yang H; Xie L; Long H; Jiang R
    Mol Med Rep; 2019 Apr; 19(4):2707-2715. PubMed ID: 30720096
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.